Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)
Publication date
2024-03
Authors
Rinnooy Kan, Charlotte E.
Röckmann, Heike
van Dijk, M.R.
Ramsaransing, Tanuja
Reubsaet, Lieke L.
Peters, Elke E.M.
Vos, Lydia E.
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID-19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) COVID-19 vaccination, respectively.
Keywords
bullous cutaneous reaction, bullous eruption, COVID-19 mRNA vaccination, Pfizer and Moderna COVID-19 vaccination, reactive dermatitis, Dermatology
Citation
Rinnooy Kan, C E, Röckmann, H, van Dijk, M R, Ramsaransing, T, Reubsaet, L L, Peters, E E M & Vos, L E 2024, 'Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)', JEADV: Clinical Practice, vol. 3, no. 1, pp. 275-279. https://doi.org/10.1002/jvc2.273